Factors influencing postischemic cerebral vascular obstruction.
D000740:Anemia; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001011:Aorta; D004837:Epinephrine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006487:Hemostasis; D006935:Hypercapnia; D006985:Hyperventilation; D000860:Hypoxia; D002542:Intracranial Embolism and Thrombosis / Q000517:prevention & control*; D002546:Ischemic Attack, Transient / Q000150:complications*; D008353:Mannitol / Q000627:therapeutic use; D009994:Osmolar Concentration; D011817:Rabbits
D000925:Anticoagulants; D005938:Glucocorticoids; D008353:Mannitol; D005947:Glucose; D004837:Epinephrine